ST
Smithfield Trust Portfolio holdings
AUM
$2.12B
1-Year Return
11.32%
This Quarter Return
-13.61%
1 Year Return
+11.32%
3 Year Return
+38.41%
5 Year Return
+57.96%
10 Year Return
+111.66%
AUM
$955M
AUM Growth
-$122M
(-11%)
Cap. Flow
+$45.6M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
50.18%
Holding
1,046
New
91
Increased
163
Reduced
307
Closed
112
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
+$23.6M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$15.3M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$11.4M |
| 4 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.04M |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$4.81M |
Top Sells
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$15.3M |
| 2 |
iShares Short Maturity Bond ETF
NEAR
|
+$9.48M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$7.14M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$3.99M |
| 5 |
iShare MSCI Eurozone ETF
EZU
|
+$2.24M |
Sector Composition
| 1 | Technology | 5.72% |
| 2 | Financials | 3.93% |
| 3 | Healthcare | 3.7% |
| 4 | Consumer Staples | 2.75% |
| 5 | Industrials | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Marriott International Class A Common Stock
MAR
$72.8B
| $17K | ﹤0.01% |
231
+125
| +118% | +$9.2K |
|
602
Matthews International
MATW
$767M
| $17K | ﹤0.01% |
700
| – | – |
|
603
NRG Energy
NRG
$29.5B
| $17K | ﹤0.01% |
625
+360
| +136% | +$9.79K |
|
604
Oshkosh
OSK
$8.7B
| $17K | ﹤0.01% |
255
+210
| +467% | +$14K |
|
605
Centene
CNC
$15.3B
| $16K | ﹤0.01% |
274
+54
| +25% | +$3.15K |
|
606
Eastman Chemical
EMN
$7.91B
| $16K | ﹤0.01% |
335
| – | – |
|
607
Evolent Health
EVH
$1.16B
| $16K | ﹤0.01% |
+3,000
| New | +$16K |
|
608
Haemonetics
HAE
$2.61B
| $16K | ﹤0.01% |
161
-409
| -72% | -$40.6K |
|
609
Kellanova
K
$27.6B
| $16K | ﹤0.01% |
292
| – | – |
|
610
Kemper
KMPR
$3.35B
| $16K | ﹤0.01% |
206
+170
| +472% | +$13.2K |
|
611
Lamb Weston
LW
$8.02B
| $16K | ﹤0.01% |
276
| – | – |
|
612
Teva Pharmaceuticals
TEVA
$22.6B
| $16K | ﹤0.01% |
1,759
| – | – |
|
613
Cardinal Health
CAH
$36B
| $15K | ﹤0.01% |
310
| – | – |
|
614
Check Point Software Technologies
CHKP
$21.1B
| $15K | ﹤0.01% |
150
| – | – |
|
615
Charles River Laboratories
CRL
$7.97B
| $15K | ﹤0.01% |
115
+45
| +64% | +$5.87K |
|
616
Curtiss-Wright
CW
$18.2B
| $15K | ﹤0.01% |
166
+126
| +315% | +$11.4K |
|
617
HDFC Bank
HDB
$181B
| $15K | ﹤0.01% |
400
| – | – |
|
618
Idacorp
IDA
$6.68B
| $15K | ﹤0.01% |
180
+50
| +38% | +$4.17K |
|
619
iShares Core S&P Total US Stock Market ETF
ITOT
$75.9B
| $15K | ﹤0.01% |
+256
| New | +$15K |
|
620
James River Group
JRVR
$247M
| $15K | ﹤0.01% |
404
-2,070
| -84% | -$76.9K |
|
621
Northwest Bancshares
NWBI
$1.86B
| $15K | ﹤0.01% |
1,300
| – | – |
|
622
Old Republic International
ORI
$10B
| $15K | ﹤0.01% |
1,000
-200
| -17% | -$3K |
|
623
Pacific Biosciences
PACB
$393M
| $15K | ﹤0.01% |
4,862
| – | – |
|
624
Primerica
PRI
$8.9B
| $15K | ﹤0.01% |
173
-849
| -83% | -$73.6K |
|
625
ResMed
RMD
$40.9B
| $15K | ﹤0.01% |
100
-1,378
| -93% | -$207K |
|